Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,704 | 53,126 | 60,357 | 68,117 | 57,064 |
| Marketable Securities | 9,868 | 9,503 | 12,588 | 10,948 | 9,309 |
| Receivables | 9,803 | 5,418 | 5,767 | 5,838 | 4,645 |
| Inventories | 1,907 | 1,727 | 3,475 | 2,994 | 1,356 |
| TOTAL | $61,970 | $71,964 | $83,505 | $89,014 | $74,025 |
| Non-Current Assets | |||||
| PPE Net | 12,712 | 6,778 | 3,348 | 1,876 | 2,062 |
| Investments And Advances | 40,128 | 34,177 | 34,679 | 34,870 | 29,442 |
| Intangibles | 12,203 | 12,358 | 12,691 | 12,834 | 13,210 |
| Other Non-Current Assets | 11,285 | 10,997 | 10,303 | 9,499 | 8,995 |
| TOTAL | $76,328 | $64,310 | $61,021 | $59,079 | $53,709 |
| Total Assets | $138,298 | $136,274 | $144,526 | $148,093 | $127,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,084 | 1,548 | 1,525 | 826 |
| Accounts payable and accrued liabilities | 2,223 | 6,324 | 5,519 | 5,741 | 3,260 |
| Accrued Expenses | 10,963 | 2,550 | 2,488 | 2,238 | 3,424 |
| TOTAL | $13,186 | $9,958 | $10,021 | $9,970 | $7,976 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 37,576 | 37,162 | 37,149 | 35,561 | 35,692 |
| TOTAL | $40,610 | $39,709 | $39,705 | $38,091 | $38,218 |
| Total Liabilities | $53,796 | $49,667 | $49,726 | $48,061 | $46,194 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,659 | 13,980 | 13,980 | 13,980 | 13,980 |
| Common Shares | 1 | 1,399 | 1,399 | 1,399 | 1,240 |
| Retained earnings | -605,643 | -599,968 | -590,263 | -583,836 | -570,501 |
| Other shareholders' equity | 1,920 | 1,135 | 1,125 | 451 | 555 |
| TOTAL | $84,502 | $86,607 | $94,800 | $100,032 | $81,540 |
| Total Liabilities And Equity | $138,298 | $136,274 | $144,526 | $148,093 | $127,734 |